Lilly and Diversity in Oncology Trials

We sit down with Stacey Bledsoe, the Advisor for Clinical Trial Diversity at Eli Lilly and Company (Lilly) to talk about what is being done in the industry to advance diversity in clinical trials. Stacey touches specifically on some of the work Lilly is doing, as well as diving specifically into the Oncology therapeutic area. The needs of this community are different, yet just as important as others yet at times does not get the attention it needs. Stacey gives us lessons that we can apply to our trials at both the Sponsor and CRO level, as well as the site community.